Concepedia

Author

Jorge Saucedo

NorthShore University HealthSystem

Also Known As

J Saucedo, J. Saucedo, JORGE SAUCEDO, Jorge Saucedo, Juan Pablo Saucedo

106

Publications

2.6K

Citations

24

H-Index

46

Concepts

All Affiliations

NorthShore University HealthSystemKerckhoff KlinikLibin Cardiovascular Institute of AlbertaUniversity Clinic of TraumatologyHospital São Rafael
JS

About

Jorge Saucedo is an author at NorthShore University HealthSystem specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

18

1.3K

2

Public Health

3

3

456

3

Health Sciences

1

1

24

4

Cell Biology

1

1

41

5

Diabetes

1

1

115

Jorge Saucedo

×

28

Publications

1.8K

Citations

21

H-Index

YearCitations

Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial

Douglass A. Morrison, Gulshan K. Sethi, Jerome Sacks,

Journal of the American College of Cardiology

2001

306

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States

Issam Moussa, Divyanshu Mohananey, Jorge Saucedo,

Journal of the American College of Cardiology

2020

252

Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States

Mayra Guerrero, Sreekanth Vemulapalli, Qun Xiang,

Circulation Cardiovascular Interventions

2020

196

Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass

Steven P. Sedlis, Douglass A. Morrison, Jeffrey D. Lorin,

Journal of the American College of Cardiology

2002

115

Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy

Mario Iannaccone, Fabrizio D’Ascenzo, Paolo Vadalà,

European Heart Journal Acute Cardiovascular Care

2017

115

Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial

Sanjay Rajagopalan, Emile R. Mohler, Robert J. Lederman,

American Heart Journal

2003

92

Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score

Sergio Raposeiras‐Roubín, Jonas Faxén, Andrés Íñiguez,

International Journal of Cardiology

2018

89

Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?

Vladimír Džavík, Lynn A. Sleeper, Michael H. Picard,

American Heart Journal

2005

70

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass

Douglass A. Morrison, Gulshan K. Sethi, Jerome Sacks,

Journal of the American College of Cardiology

2002

60

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone,

Journal of the American College of Cardiology

2017

56

Page 1